Multidisciplinary Thoracic Oncology Conference 2026: Advances in Lung Cancer, Thoracic Malignancies, Immunotherapy, and Precision Medicine | Los Angeles
Accreditation: 5.75 Nursing Contact Hours | 5.75 ABIM MOC II | 5.75 AMA PRA Category 1 Credit™ | 5.75 ACPE Pharmacy
Venue: Omni Los Angeles Hotel at California Plaza, 251 S Olive St , Los Angeles, CA , 90012
Official conference page for Multidisciplinary Thoracic Oncology Conference 2026: Advances in Lung Cancer, Thoracic Malignancies, Immunotherapy, and Precision Medicine | Los Angeles . https://binaytara.org/projects/conferences/2026-thoracic-oncology-los-angeles
About Multidisciplinary Thoracic Oncology Conference 2026: Advances in Lung Cancer, Thoracic Malignancies, Immunotherapy, and Precision Medicine | Los Angeles


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Agenda
Saturday, November 7th, 2026
All timings are in Pacific Time (PDT, GMT-07:00) time.
08:05 AM - 08:20 AM
Role of Food and Other Carcinogens in Lung Cancer – Robert Hsu, MD
08:20 AM - 08:35 AM
Lung Cancer Detection in Never Smokers – Miguel Angel Villalona-Calero, MD
08:35 AM - 08:50 AM
AI in Detecting Early Lung Cancer and Recurrence
08:50 AM - 09:05 AM
Role of ctDNA in Early Stage Lung Cancer
09:05 AM - 09:15 AM
Case Presentation
09:15 AM - 09:35 AM
Case-based Panel Discussion
09:35 AM - 09:45 AM
Insights into ADCs
09:45 AM - 09:55 AM
Novel Targeted Treatment Strategies – Kamya Sankar, MD
09:55 AM - 10:05 AM
Updates on IO treatments
10:05 AM - 10:20 AM
Panel Discussion
11:05 AM - 11:20 AM
Stage IIIA – Percy Lee, MD
11:20 AM - 11:35 AM
Stage IIIB/IIIC
11:35 AM - 11:50 AM
Stage IV Oligometastatic Disease – Jason Ye, MD
11:50 AM - 12:05 PM
Stage IV Polymetastatic Disease – Arter Liao Zhaohui, MD
12:05 PM - 12:15 PM
Case Presentation
12:15 PM - 12:35 PM
Cased-Based Panel Discussion
Panelists:
Diana Hsu, MD; Ravi Salgia , MD
02:35 PM - 02:50 PM
Managing Immune-Related Adverse Events (irAEs) from IO Therapy – David Berz, MD
02:50 PM - 03:05 PM
Managing TKI-Related Toxicities
03:05 PM - 03:20 PM
Managing ADC-Related Toxicities
03:20 PM - 03:35 PM
Panel Discussion
04:20 PM - 04:35 PM
SCLC Case
04:35 PM - 04:50 PM
Stage III or IV Thymoma Case – Dan Raz, MD
04:50 PM - 05:05 PM
Epithelioid Mesothelioma Case – Matthew Gubens, MD, MS
05:05 PM - 05:20 PM
Panel Discussion
